IMNM peer analysis
Immunome (IMNM) against its competitors: price, today's move, 1-year return and market value side by side.
IMNM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -27.58% | – |
| BCYC Bicycle Therapeutics | $3.60 | 3.45% | -40.84% | $243.93M |
| CLDX Celldex Therapeutics | $30.00 | 6.12% | 25.83% | $2.22B |
| CRVS Corvus Pharmaceuticals | $10.60 | 8.94% | 42.23% | $818.50M |
| IMCR Immunocore | $30.99 | 9.12% | -2.34% | – |
| IMMX Immix Biopharma | $7.99 | 10.97% | 164.59% | – |
| IMTX Immatics | $6.36 | 2.91% | -29.75% | – |
| MGNX MacroGenics | $2.33 | 4.95% | 68.40% | $141.41M |
| SLS SELLAS Life Sciences | $8.33 | 5.71% | 378.57% | $1.59B |
| STRO Sutro Biopharma | $9.62 | 4.57% | -3.06% | $152.55M |
| IMNM Immunome | $19.48 | 8.80% | 22.21% | – |
- IMNM's peers: AVBP (ArriVent BioPharma), BCYC (Bicycle Therapeutics), CLDX (Celldex Therapeutics), CRVS (Corvus Pharmaceuticals), IMCR (Immunocore), IMMX (Immix Biopharma), IMTX (Immatics), MGNX (MacroGenics).
Updated 2026-11-07 11:55 UTC